Complications of second-trimester medical termination of pregnancy for fetal anomalies compared with intrauterine fetal demise.

Testani, Erica; Latta, Kristen; Barker, Emily; York, Sloane L; Laursen, Laura

Testani, Erica; Latta, Kristen; Barker, Emily; York, Sloane L; Laursen, Laura.

Affiliation

Testani E; From the Department of Obstetrics and Gynecology, Rush University Medical Center, Chicago, Illinois, USA.
Latta K; From the Department of Obstetrics and Gynecology, Rush University Medical Center, Chicago, Illinois, USA.
Barker E; From the Department of Obstetrics and Gynecology, Rush University Medical Center, Chicago, Illinois, USA.
York SL; From the Department of Obstetrics and Gynecology, Rush University Medical Center, Chicago, Illinois, USA.
Laursen L; From the Department of Obstetrics and Gynecology, Rush University Medical Center, Chicago, Illinois, USA.

Int J Gynaecol Obstet ; 160(1): 145-149, 2023 Jan.

Article in En | MEDLINE | ID: mdl-35695042

Subject(s)

Abortifacient Agents, Nonsteroidal; Abortion, Induced; Fetal Diseases; Misoprostol; Pregnancy; Female; Humans; Adult; Misoprostol/adverse effects; Mifepristone/adverse effects; Pregnancy Trimester, Second; Retrospective Studies; Fetal Death; Abortion, Induced/adverse effects; Stillbirth

Key words

complications; intrauterine fetal demise; second-trimester induction of labor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Abortifacient Agents, Nonsteroidal / Misoprostol / Abortion, Induced / Fetal Diseases Type of study: Observational_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Int J Gynaecol Obstet Year: 2023 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google